Market Experts' LIVE Stock Recommendations: Hold Garden Reach, Buy Aurobindo Pharma

IDBI Capital suggested a buy for Aditya Birla Capital. The target price is Rs 273 apiece, and the stop loss is at Rs 245 apiece.

Vedanta has approved its first interim dividend of Rs 7 per share for the fiscal year 2026. The company has also sanctioned the payment of Rs 2,737 crore in interim dividends. 

The Streets Trading Strategist and Fund Manager Kunal Rambhia suggested a buy for Indian Overseas Bank Ltd. The target price is Rs 41. The stop loss is at Rs 36 apiece.

Dalmia Bharat received a buy target from Reliance Securities. Its equity research head gave a target price of Rs 2,250 apiece. The stop loss is at Rs 1,930 apiece.

• Novartis and MSN have settled on 659 patent for Drug entresto

• The legal fight now moves to the next patent.

• Patent for entresto expires in Nov-26 and related exclusivity expires in May-27.

• This can see upgrades in Divi's Labs FY26 and FY27 numbers.

• Divis Lab supplies API for Entresto

• Contributes 8% to Divis Lab Revenue

Reliance Securities' Vikas Jain advises buying Torrent Power Ltd. with a stop loss at Rs 1,350 and a target price of Rs 1,545. Out of 10 analysts tracking the company, three maintain a 'buy' rating, three recommend a 'hold,' and four suggest 'sell,' according to Bloomberg data. The average 12-month consensus price target implies a downside of 2.6%.

• Citi Research retained a Buy with target price Rs 7,700, which implied a 27% upside.

• Demand trend for cables continues to remain robust

• Strong demand led by improved government capex; higher capex in power sector

• Power sector further aiding increased demand of higher cable consumption

• Wires demand likely to improve led by uptick in residential demand in tier 2-5 towns

• For FMEG, aiming to improve margins every year and reach 8-10% by FY30

Nomura upgraded IndusInd Bank Ltd. to Neutral as the lender has a clear intent to make itself clean in financial year 2026. The brokerage also hiked the target price to Rs 1,050 apiece.

Vaibhav Vidwani, equity research analyst at Bonanza Portfolio suggested to to enter Aurobindo Pharma. The stock shows strong potential and the ability to perform well in the long run.

Ravi Singh, senior vice president of retail research at Religare Broking suggested a hold for Garden Reach Shipbuilders & Engineers Ltd. The company is backed by strong leadership, indicating a potential upside movement toward Rs 3,600. Singh suggested to maintain a stop-loss at Rs 3,000.